
Charles Schwab (SCHW) Stock Forecast & Price Target
Charles Schwab (SCHW) Analyst Ratings
Bulls say
Charles Schwab is viewed positively because its core franchise is compounding on multiple fronts: 3Q26 adjusted EPS rose 29% YoY to $1.69, revenue increased 17% to a record $7.17B, and core net new assets hit a quarterly record $190.4B, underscoring strong organic growth and operating leverage. Despite a slower NIM update, the firm’s client behavior is constructive, with loans up 35% YoY to $72.3B, assets reaching $13.3T, and active brokerage accounts rising to 40.3M, while AI and digital tools appear more likely to deepen engagement and improve productivity than to disintermediate the platform. Strong expense control, rising capital generation, and a path to substantially higher repurchases support a favorable earnings mix and a resilient long-term return profile.
Bears say
Charles Schwab is facing a more cautious earnings and margin outlook as management guided 4Q26E NIM to 3.15% to 3.20%, below prior expectations, while also signaling 9.5% Y/Y cost growth and only 800 bps of leverage in '26FY. The firm’s core earnings engine remains vulnerable because client sweep cash and cash monetization economics may not fully fund loan growth, forcing greater wholesale funding and modestly clipping NIM, while falling rates would further pressure net interest income and sweep revenues. Despite strong growth in PAL and client margin balances, the negative view is reinforced by risks of deeper balance-sheet contraction in '26, slower supplemental borrowing paydown, and renewed client cash sorting if rates rise.
This aggregate rating is based on analysts' research of Charles Schwab and is not a guaranteed prediction by Public.com or investment advice.
Charles Schwab (SCHW) Analyst Forecast & Price Prediction
Start investing in Charles Schwab (SCHW)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Charles Schwab (SCHW) Forecast
Charles Schwab (SCHW) Analyst Forecast & Price Prediction
Start investing in Charles Schwab (SCHW)
Order type
Buy in
Order amount
Est. shares
0 shares